Dr. A Dimitrios Colevas, MD
Claim this profileStanford University
Studies Nasopharyngeal Carcinoma
Studies Nasopharyngeal Cancer
8 reported clinical trials
12 drugs studied
Area of expertise
1Nasopharyngeal Carcinoma
Stage IV
Stage III
PD-L1 positive
2Nasopharyngeal Cancer
Stage IV
Stage III
PD-L1 positive
Affiliated Hospitals
Clinical Trials A Dimitrios Colevas, MD is currently running
Gemcitabine + Docetaxel + Toripalimab
for Nasopharyngeal Cancer
The purpose of the research is to test the safety and efficacy of the investigational drug in human subjects with cancer.
Recruiting1 award Phase 26 criteria
Pembrolizumab
for Thyroid Cancer
This is a single-arm, open-label trial designed to evaluate the activity of pembrolizumab therapy in anaplastic thyroid cancer in patients with no curative alternative therapy. Pembrolizumab (Keytruda-Merck) 200 mg, given IV every 3 weeks, until evidence of progression, intolerance of treatment, withdrawal of consent or death
Recruiting1 award Phase 28 criteria
More about A Dimitrios Colevas, MD
Clinical Trial Related6 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments A Dimitrios Colevas, MD has experience with
- Pembrolizumab
- Toripalimab
- INBRX-105
- RP1
- Cemiplimab
- Ad/PNP
Breakdown of trials A Dimitrios Colevas, MD has run
Nasopharyngeal Carcinoma
Nasopharyngeal Cancer
Squamous Cell Carcinoma
Neck Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does A Dimitrios Colevas, MD specialize in?
A Dimitrios Colevas, MD focuses on Nasopharyngeal Carcinoma and Nasopharyngeal Cancer. In particular, much of their work with Nasopharyngeal Carcinoma has involved Stage IV patients, or patients who are Stage III.
Is A Dimitrios Colevas, MD currently recruiting for clinical trials?
Yes, A Dimitrios Colevas, MD is currently recruiting for 2 clinical trials in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that A Dimitrios Colevas, MD has studied deeply?
Yes, A Dimitrios Colevas, MD has studied treatments such as Pembrolizumab, Toripalimab, INBRX-105.
What is the best way to schedule an appointment with A Dimitrios Colevas, MD?
Apply for one of the trials that A Dimitrios Colevas, MD is conducting.
What is the office address of A Dimitrios Colevas, MD?
The office of A Dimitrios Colevas, MD is located at: Stanford University, Palo Alto, California 94304 United States. This is the address for their practice at the Stanford University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.